ClinVar Miner

Submissions for variant NM_000321.3(RB1):c.958C>T (p.Arg320Ter)

dbSNP: rs121913300
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine RCV000114716 SCV000087348 pathogenic Retinoblastoma 2024-05-20 criteria provided, single submitter clinical testing Case and Pedigree Information: BILATERAL CASES:20, UNILATERAL CASES:2, TOTAL CASES:22, PEDIGREES:22. ACMG Codes Applied:PVS1, PM2, PS4S
Ambry Genetics RCV000492534 SCV000580769 pathogenic Hereditary cancer-predisposing syndrome 2021-11-01 criteria provided, single submitter clinical testing The p.R320* pathogenic mutation (also known as c.958C>T), located in coding exon 10 of the RB1 gene, results from a C to T substitution at nucleotide position 958. This changes the amino acid from an arginine to a stop codon within coding exon 10. This mutation has been reported in numerous individuals affected with sporadic and familial retinoblastoma both bilaterally and unilaterally (Lohmann DR et al. Am. J. Hum. Genet. 1996 May;58(5):940-9; Richter S et al. Am. J. Hum. Genet. 2003 Feb;72(2):253-69; Alonso J et al. Hum. Mutat. 2005 Jan;25(1):99; Choy KW et al. Hum. Mutat. 2002 Nov;20(5):408; Houdayer C et al. Hum. Mutat. 2004 Feb; 23(2):193-202). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Invitae RCV000114716 SCV000754146 pathogenic Retinoblastoma 2023-08-30 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg320*) in the RB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with bilateral retinoblastoma and retinoblastoma (PMID: 7704558, 12541220, 15605413, 24225018, 24810223, 25754945, 28575107). In at least one individual the variant was observed to be de novo. This variant is also known as g.64348C>T. ClinVar contains an entry for this variant (Variation ID: 126824). For these reasons, this variant has been classified as Pathogenic.
Department of Pediatrics, Memorial Sloan Kettering Cancer Center RCV000114716 SCV001478172 pathogenic Retinoblastoma 2020-12-15 criteria provided, single submitter research
GeneDx RCV001558107 SCV001779984 pathogenic not provided 2023-03-22 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); Observed in multiple individuals with retinoblastoma (Lohmann et al., 1996; Choy et al., 2002; Alonso et al., 2005; Sagi et al., 2015; Tomar et al., 2017); This variant is associated with the following publications: (PMID: 19280657, 34190019, 8651278, 12402348, 33493472, 7704558, 28575107, 25754945, 12541220, 15605413, 27983729, 14722923, 18840911, 34308366, 34294096, 33456302, 31772335, 34277001, 34645364, 35960463, 33318192)
Genetics and Molecular Pathology, SA Pathology RCV000114716 SCV004175605 pathogenic Retinoblastoma 2023-03-22 criteria provided, single submitter clinical testing The RB1 c.958C>T variant is classified as pathogenic (PVS1, PM6, PS4, PM2, PM3) The RB1 c.958C>T variant is a single nucleotide change which is predicted to result in premature termination of the protein product at codon 320 (PVS1). This variant has been identified as a de novo variant in at least four unrelated patients (PMID:33456302) (PM6). The variant has been widely reported in patients with retinoblastoma, both as germline, somatic and mosaic(PMID:33456302, PMID:28575107) (PS4). This variant is absent from population databases (PM2). This variant has been detected in trans with a somatic pathogenic variant (PMID:28575107) (PM3). The variant has been reported in dbSNP (rs121913300) and in the HGMD database as disease causing (CM941205). It has been reported as Pathogenic by other diagnostic laboratories (ClinVar Variation ID: 126824) and in the RB1 variant database (LOVD RB1-000072).
Database of Curated Mutations (DoCM) RCV000114716 SCV000504837 likely pathogenic Retinoblastoma 2015-07-14 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.